Insiders · Profile

Yamashita Elizabeth A.

VP, Regulatory Affairs at Outlook Therapeutics. Filing since 18 Dec 2017. CIK 0001663252

Company
Date
Role
Action
Shares
Amount
Of holding
22 Dec 2017
VP, Regulatory Affairs
Sold, plan not stated
16,170
$18.27K
20.0%
19 Dec 2017
VP, Regulatory Affairs
Sold, plan not stated
6,151
$7.01K
7.1%
18 Dec 2017
VP, Regulatory Affairs
Sold, plan not stated
1,509
$1.77K
1.7%
3 decisions on file.